nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—CYP2A6—Ifosfamide—testicular cancer	0.295	0.456	CbGbCtD
Formoterol—CYP2C19—Ifosfamide—testicular cancer	0.122	0.189	CbGbCtD
Formoterol—CYP2C9—Ifosfamide—testicular cancer	0.102	0.157	CbGbCtD
Formoterol—CYP2C9—Cisplatin—testicular cancer	0.0494	0.0762	CbGbCtD
Formoterol—CYP2D6—Vinblastine—testicular cancer	0.0493	0.076	CbGbCtD
Formoterol—CYP2D6—Doxorubicin—testicular cancer	0.0303	0.0467	CbGbCtD
Formoterol—Dehydration—Doxorubicin—testicular cancer	0.000441	0.00125	CcSEcCtD
Formoterol—Upper respiratory tract infection—Methotrexate—testicular cancer	0.00044	0.00125	CcSEcCtD
Formoterol—Tachycardia—Etoposide—testicular cancer	0.000438	0.00124	CcSEcCtD
Formoterol—Dyspnoea—Cisplatin—testicular cancer	0.000437	0.00124	CcSEcCtD
Formoterol—Skin disorder—Etoposide—testicular cancer	0.000436	0.00124	CcSEcCtD
Formoterol—Dry skin—Doxorubicin—testicular cancer	0.000434	0.00123	CcSEcCtD
Formoterol—Hypokalaemia—Doxorubicin—testicular cancer	0.000431	0.00122	CcSEcCtD
Formoterol—Angina pectoris—Epirubicin—testicular cancer	0.000431	0.00122	CcSEcCtD
Formoterol—Bronchitis—Epirubicin—testicular cancer	0.000426	0.00121	CcSEcCtD
Formoterol—Diarrhoea—Dactinomycin—testicular cancer	0.000425	0.00121	CcSEcCtD
Formoterol—Nasopharyngitis—Doxorubicin—testicular cancer	0.000424	0.0012	CcSEcCtD
Formoterol—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000423	0.0012	CcSEcCtD
Formoterol—Vomiting—Bleomycin—testicular cancer	0.000423	0.0012	CcSEcCtD
Formoterol—Hypotension—Etoposide—testicular cancer	0.00042	0.00119	CcSEcCtD
Formoterol—Rash—Bleomycin—testicular cancer	0.000419	0.00119	CcSEcCtD
Formoterol—Gastritis—Doxorubicin—testicular cancer	0.000419	0.00119	CcSEcCtD
Formoterol—Pain—Cisplatin—testicular cancer	0.000419	0.00119	CcSEcCtD
Formoterol—Dermatitis—Bleomycin—testicular cancer	0.000419	0.00119	CcSEcCtD
Formoterol—Hypersensitivity—Ifosfamide—testicular cancer	0.000419	0.00119	CcSEcCtD
Formoterol—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000411	0.00117	CcSEcCtD
Formoterol—Conjunctivitis—Methotrexate—testicular cancer	0.00041	0.00116	CcSEcCtD
Formoterol—Influenza—Doxorubicin—testicular cancer	0.00041	0.00116	CcSEcCtD
Formoterol—Asthma—Doxorubicin—testicular cancer	0.00041	0.00116	CcSEcCtD
Formoterol—Asthenia—Ifosfamide—testicular cancer	0.000408	0.00116	CcSEcCtD
Formoterol—Feeling abnormal—Cisplatin—testicular cancer	0.000404	0.00115	CcSEcCtD
Formoterol—Pruritus—Ifosfamide—testicular cancer	0.000402	0.00114	CcSEcCtD
Formoterol—Haematuria—Methotrexate—testicular cancer	0.000402	0.00114	CcSEcCtD
Formoterol—Dyspnoea—Etoposide—testicular cancer	0.0004	0.00114	CcSEcCtD
Formoterol—Hyperglycaemia—Epirubicin—testicular cancer	0.000399	0.00113	CcSEcCtD
Formoterol—Somnolence—Etoposide—testicular cancer	0.000399	0.00113	CcSEcCtD
Formoterol—Angina pectoris—Doxorubicin—testicular cancer	0.000399	0.00113	CcSEcCtD
Formoterol—Nausea—Bleomycin—testicular cancer	0.000395	0.00112	CcSEcCtD
Formoterol—Vomiting—Dactinomycin—testicular cancer	0.000394	0.00112	CcSEcCtD
Formoterol—Bronchitis—Doxorubicin—testicular cancer	0.000394	0.00112	CcSEcCtD
Formoterol—Rash—Dactinomycin—testicular cancer	0.000391	0.00111	CcSEcCtD
Formoterol—Diarrhoea—Ifosfamide—testicular cancer	0.000389	0.0011	CcSEcCtD
Formoterol—Gastrointestinal disorder—Etoposide—testicular cancer	0.000388	0.0011	CcSEcCtD
Formoterol—Body temperature increased—Cisplatin—testicular cancer	0.000387	0.0011	CcSEcCtD
Formoterol—Fatigue—Etoposide—testicular cancer	0.000387	0.0011	CcSEcCtD
Formoterol—Constipation—Etoposide—testicular cancer	0.000384	0.00109	CcSEcCtD
Formoterol—Pain—Etoposide—testicular cancer	0.000384	0.00109	CcSEcCtD
Formoterol—Conjunctivitis—Epirubicin—testicular cancer	0.000384	0.00109	CcSEcCtD
Formoterol—Urinary tract infection—Epirubicin—testicular cancer	0.000384	0.00109	CcSEcCtD
Formoterol—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000381	0.00108	CcSEcCtD
Formoterol—Haematuria—Epirubicin—testicular cancer	0.000376	0.00107	CcSEcCtD
Formoterol—Dizziness—Ifosfamide—testicular cancer	0.000376	0.00107	CcSEcCtD
Formoterol—Pharyngitis—Methotrexate—testicular cancer	0.000376	0.00107	CcSEcCtD
Formoterol—Urinary tract disorder—Methotrexate—testicular cancer	0.000374	0.00106	CcSEcCtD
Formoterol—Urethral disorder—Methotrexate—testicular cancer	0.000371	0.00105	CcSEcCtD
Formoterol—Sinusitis—Epirubicin—testicular cancer	0.00037	0.00105	CcSEcCtD
Formoterol—Feeling abnormal—Etoposide—testicular cancer	0.00037	0.00105	CcSEcCtD
Formoterol—Hyperglycaemia—Doxorubicin—testicular cancer	0.000369	0.00105	CcSEcCtD
Formoterol—Nausea—Dactinomycin—testicular cancer	0.000369	0.00105	CcSEcCtD
Formoterol—Gastrointestinal pain—Etoposide—testicular cancer	0.000367	0.00104	CcSEcCtD
Formoterol—Visual impairment—Methotrexate—testicular cancer	0.000365	0.00104	CcSEcCtD
Formoterol—Vomiting—Ifosfamide—testicular cancer	0.000362	0.00103	CcSEcCtD
Formoterol—Hypersensitivity—Cisplatin—testicular cancer	0.000361	0.00103	CcSEcCtD
Formoterol—Rash—Ifosfamide—testicular cancer	0.000358	0.00102	CcSEcCtD
Formoterol—Dermatitis—Ifosfamide—testicular cancer	0.000358	0.00102	CcSEcCtD
Formoterol—Urticaria—Etoposide—testicular cancer	0.000357	0.00101	CcSEcCtD
Formoterol—Rhinitis—Epirubicin—testicular cancer	0.000355	0.00101	CcSEcCtD
Formoterol—Abdominal pain—Etoposide—testicular cancer	0.000355	0.00101	CcSEcCtD
Formoterol—Body temperature increased—Etoposide—testicular cancer	0.000355	0.00101	CcSEcCtD
Formoterol—Urinary tract infection—Doxorubicin—testicular cancer	0.000355	0.00101	CcSEcCtD
Formoterol—Conjunctivitis—Doxorubicin—testicular cancer	0.000355	0.00101	CcSEcCtD
Formoterol—Asthenia—Cisplatin—testicular cancer	0.000352	0.000999	CcSEcCtD
Formoterol—Pharyngitis—Epirubicin—testicular cancer	0.000352	0.000999	CcSEcCtD
Formoterol—Cardiac disorder—Methotrexate—testicular cancer	0.000351	0.000998	CcSEcCtD
Formoterol—Urinary tract disorder—Epirubicin—testicular cancer	0.00035	0.000994	CcSEcCtD
Formoterol—Oedema peripheral—Epirubicin—testicular cancer	0.000349	0.000991	CcSEcCtD
Formoterol—Haematuria—Doxorubicin—testicular cancer	0.000348	0.000989	CcSEcCtD
Formoterol—Connective tissue disorder—Epirubicin—testicular cancer	0.000348	0.000989	CcSEcCtD
Formoterol—Urethral disorder—Epirubicin—testicular cancer	0.000347	0.000986	CcSEcCtD
Formoterol—Sinusitis—Doxorubicin—testicular cancer	0.000343	0.000973	CcSEcCtD
Formoterol—Immune system disorder—Methotrexate—testicular cancer	0.000342	0.000971	CcSEcCtD
Formoterol—Visual impairment—Epirubicin—testicular cancer	0.000341	0.00097	CcSEcCtD
Formoterol—Mediastinal disorder—Methotrexate—testicular cancer	0.000341	0.000969	CcSEcCtD
Formoterol—Nausea—Ifosfamide—testicular cancer	0.000338	0.000959	CcSEcCtD
Formoterol—Diarrhoea—Cisplatin—testicular cancer	0.000335	0.000953	CcSEcCtD
Formoterol—Mental disorder—Methotrexate—testicular cancer	0.000332	0.000942	CcSEcCtD
Formoterol—Hypersensitivity—Etoposide—testicular cancer	0.000331	0.00094	CcSEcCtD
Formoterol—Malnutrition—Methotrexate—testicular cancer	0.00033	0.000936	CcSEcCtD
Formoterol—Cardiac disorder—Epirubicin—testicular cancer	0.000329	0.000934	CcSEcCtD
Formoterol—Rhinitis—Doxorubicin—testicular cancer	0.000329	0.000933	CcSEcCtD
Formoterol—Pharyngitis—Doxorubicin—testicular cancer	0.000325	0.000924	CcSEcCtD
Formoterol—Urinary tract disorder—Doxorubicin—testicular cancer	0.000324	0.000919	CcSEcCtD
Formoterol—Oedema peripheral—Doxorubicin—testicular cancer	0.000323	0.000917	CcSEcCtD
Formoterol—Dysgeusia—Methotrexate—testicular cancer	0.000323	0.000917	CcSEcCtD
Formoterol—Asthenia—Etoposide—testicular cancer	0.000322	0.000915	CcSEcCtD
Formoterol—Connective tissue disorder—Doxorubicin—testicular cancer	0.000322	0.000915	CcSEcCtD
Formoterol—Urethral disorder—Doxorubicin—testicular cancer	0.000321	0.000913	CcSEcCtD
Formoterol—Immune system disorder—Epirubicin—testicular cancer	0.00032	0.000909	CcSEcCtD
Formoterol—Mediastinal disorder—Epirubicin—testicular cancer	0.000319	0.000907	CcSEcCtD
Formoterol—Back pain—Methotrexate—testicular cancer	0.000319	0.000905	CcSEcCtD
Formoterol—Pruritus—Etoposide—testicular cancer	0.000318	0.000902	CcSEcCtD
Formoterol—Arrhythmia—Epirubicin—testicular cancer	0.000317	0.000899	CcSEcCtD
Formoterol—Visual impairment—Doxorubicin—testicular cancer	0.000316	0.000897	CcSEcCtD
Formoterol—Vomiting—Cisplatin—testicular cancer	0.000312	0.000885	CcSEcCtD
Formoterol—Mental disorder—Epirubicin—testicular cancer	0.00031	0.000882	CcSEcCtD
Formoterol—Rash—Cisplatin—testicular cancer	0.000309	0.000878	CcSEcCtD
Formoterol—Dermatitis—Cisplatin—testicular cancer	0.000309	0.000877	CcSEcCtD
Formoterol—Malnutrition—Epirubicin—testicular cancer	0.000308	0.000876	CcSEcCtD
Formoterol—Diarrhoea—Etoposide—testicular cancer	0.000307	0.000873	CcSEcCtD
Formoterol—Ill-defined disorder—Methotrexate—testicular cancer	0.000306	0.000868	CcSEcCtD
Formoterol—Cardiac disorder—Doxorubicin—testicular cancer	0.000304	0.000864	CcSEcCtD
Formoterol—Tension—Epirubicin—testicular cancer	0.000303	0.00086	CcSEcCtD
Formoterol—Dysgeusia—Epirubicin—testicular cancer	0.000302	0.000858	CcSEcCtD
Formoterol—Nervousness—Epirubicin—testicular cancer	0.0003	0.000851	CcSEcCtD
Formoterol—Back pain—Epirubicin—testicular cancer	0.000298	0.000847	CcSEcCtD
Formoterol—Malaise—Methotrexate—testicular cancer	0.000297	0.000844	CcSEcCtD
Formoterol—Dizziness—Etoposide—testicular cancer	0.000297	0.000843	CcSEcCtD
Formoterol—Muscle spasms—Epirubicin—testicular cancer	0.000297	0.000842	CcSEcCtD
Formoterol—Immune system disorder—Doxorubicin—testicular cancer	0.000296	0.000841	CcSEcCtD
Formoterol—Mediastinal disorder—Doxorubicin—testicular cancer	0.000295	0.000839	CcSEcCtD
Formoterol—Arrhythmia—Doxorubicin—testicular cancer	0.000293	0.000832	CcSEcCtD
Formoterol—Nausea—Cisplatin—testicular cancer	0.000291	0.000827	CcSEcCtD
Formoterol—Cough—Methotrexate—testicular cancer	0.000288	0.000817	CcSEcCtD
Formoterol—Mental disorder—Doxorubicin—testicular cancer	0.000287	0.000816	CcSEcCtD
Formoterol—Ill-defined disorder—Epirubicin—testicular cancer	0.000286	0.000813	CcSEcCtD
Formoterol—Vomiting—Etoposide—testicular cancer	0.000286	0.000811	CcSEcCtD
Formoterol—Malnutrition—Doxorubicin—testicular cancer	0.000285	0.000811	CcSEcCtD
Formoterol—Agitation—Epirubicin—testicular cancer	0.000283	0.000805	CcSEcCtD
Formoterol—Rash—Etoposide—testicular cancer	0.000283	0.000804	CcSEcCtD
Formoterol—Dermatitis—Etoposide—testicular cancer	0.000283	0.000803	CcSEcCtD
Formoterol—Headache—Etoposide—testicular cancer	0.000281	0.000799	CcSEcCtD
Formoterol—Chest pain—Methotrexate—testicular cancer	0.000281	0.000797	CcSEcCtD
Formoterol—Myalgia—Methotrexate—testicular cancer	0.000281	0.000797	CcSEcCtD
Formoterol—Arthralgia—Methotrexate—testicular cancer	0.000281	0.000797	CcSEcCtD
Formoterol—Tension—Doxorubicin—testicular cancer	0.00028	0.000795	CcSEcCtD
Formoterol—Dysgeusia—Doxorubicin—testicular cancer	0.000279	0.000794	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000279	0.000791	CcSEcCtD
Formoterol—Malaise—Epirubicin—testicular cancer	0.000278	0.00079	CcSEcCtD
Formoterol—Discomfort—Methotrexate—testicular cancer	0.000277	0.000787	CcSEcCtD
Formoterol—Nervousness—Doxorubicin—testicular cancer	0.000277	0.000787	CcSEcCtD
Formoterol—Back pain—Doxorubicin—testicular cancer	0.000276	0.000784	CcSEcCtD
Formoterol—Muscle spasms—Doxorubicin—testicular cancer	0.000274	0.000779	CcSEcCtD
Formoterol—Palpitations—Epirubicin—testicular cancer	0.000273	0.000774	CcSEcCtD
Formoterol—Cough—Epirubicin—testicular cancer	0.000269	0.000764	CcSEcCtD
Formoterol—Anaphylactic shock—Methotrexate—testicular cancer	0.000269	0.000764	CcSEcCtD
Formoterol—Infection—Methotrexate—testicular cancer	0.000267	0.000759	CcSEcCtD
Formoterol—Nausea—Etoposide—testicular cancer	0.000267	0.000758	CcSEcCtD
Formoterol—Hypertension—Epirubicin—testicular cancer	0.000266	0.000756	CcSEcCtD
Formoterol—Ill-defined disorder—Doxorubicin—testicular cancer	0.000265	0.000752	CcSEcCtD
Formoterol—Nervous system disorder—Methotrexate—testicular cancer	0.000264	0.000749	CcSEcCtD
Formoterol—Myalgia—Epirubicin—testicular cancer	0.000263	0.000746	CcSEcCtD
Formoterol—Chest pain—Epirubicin—testicular cancer	0.000263	0.000746	CcSEcCtD
Formoterol—Arthralgia—Epirubicin—testicular cancer	0.000263	0.000746	CcSEcCtD
Formoterol—Agitation—Doxorubicin—testicular cancer	0.000262	0.000745	CcSEcCtD
Formoterol—Anxiety—Epirubicin—testicular cancer	0.000262	0.000743	CcSEcCtD
Formoterol—Skin disorder—Methotrexate—testicular cancer	0.000261	0.000742	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000261	0.000741	CcSEcCtD
Formoterol—Discomfort—Epirubicin—testicular cancer	0.000259	0.000737	CcSEcCtD
Formoterol—Malaise—Doxorubicin—testicular cancer	0.000257	0.000731	CcSEcCtD
Formoterol—Dry mouth—Epirubicin—testicular cancer	0.000257	0.000729	CcSEcCtD
Formoterol—Palpitations—Doxorubicin—testicular cancer	0.000252	0.000716	CcSEcCtD
Formoterol—Oedema—Epirubicin—testicular cancer	0.000252	0.000715	CcSEcCtD
Formoterol—Anaphylactic shock—Epirubicin—testicular cancer	0.000252	0.000715	CcSEcCtD
Formoterol—Hypotension—Methotrexate—testicular cancer	0.000251	0.000714	CcSEcCtD
Formoterol—Infection—Epirubicin—testicular cancer	0.00025	0.00071	CcSEcCtD
Formoterol—Cough—Doxorubicin—testicular cancer	0.000249	0.000707	CcSEcCtD
Formoterol—Nervous system disorder—Epirubicin—testicular cancer	0.000247	0.000701	CcSEcCtD
Formoterol—Hypertension—Doxorubicin—testicular cancer	0.000246	0.0007	CcSEcCtD
Formoterol—Tachycardia—Epirubicin—testicular cancer	0.000246	0.000698	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000245	0.000696	CcSEcCtD
Formoterol—Skin disorder—Epirubicin—testicular cancer	0.000245	0.000694	CcSEcCtD
Formoterol—Insomnia—Methotrexate—testicular cancer	0.000243	0.000691	CcSEcCtD
Formoterol—Chest pain—Doxorubicin—testicular cancer	0.000243	0.00069	CcSEcCtD
Formoterol—Myalgia—Doxorubicin—testicular cancer	0.000243	0.00069	CcSEcCtD
Formoterol—Arthralgia—Doxorubicin—testicular cancer	0.000243	0.00069	CcSEcCtD
Formoterol—Anxiety—Doxorubicin—testicular cancer	0.000242	0.000688	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000241	0.000685	CcSEcCtD
Formoterol—Discomfort—Doxorubicin—testicular cancer	0.00024	0.000682	CcSEcCtD
Formoterol—Dyspnoea—Methotrexate—testicular cancer	0.00024	0.000681	CcSEcCtD
Formoterol—Somnolence—Methotrexate—testicular cancer	0.000239	0.000679	CcSEcCtD
Formoterol—Dry mouth—Doxorubicin—testicular cancer	0.000238	0.000675	CcSEcCtD
Formoterol—Dyspepsia—Methotrexate—testicular cancer	0.000237	0.000672	CcSEcCtD
Formoterol—Hypotension—Epirubicin—testicular cancer	0.000235	0.000668	CcSEcCtD
Formoterol—Oedema—Doxorubicin—testicular cancer	0.000233	0.000661	CcSEcCtD
Formoterol—Anaphylactic shock—Doxorubicin—testicular cancer	0.000233	0.000661	CcSEcCtD
Formoterol—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000232	0.00066	CcSEcCtD
Formoterol—Fatigue—Methotrexate—testicular cancer	0.000232	0.000659	CcSEcCtD
Formoterol—Infection—Doxorubicin—testicular cancer	0.000231	0.000657	CcSEcCtD
Formoterol—Pain—Methotrexate—testicular cancer	0.00023	0.000653	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000229	0.000651	CcSEcCtD
Formoterol—Nervous system disorder—Doxorubicin—testicular cancer	0.000228	0.000649	CcSEcCtD
Formoterol—Insomnia—Epirubicin—testicular cancer	0.000228	0.000647	CcSEcCtD
Formoterol—Tachycardia—Doxorubicin—testicular cancer	0.000227	0.000646	CcSEcCtD
Formoterol—Skin disorder—Doxorubicin—testicular cancer	0.000226	0.000643	CcSEcCtD
Formoterol—Dyspnoea—Epirubicin—testicular cancer	0.000224	0.000637	CcSEcCtD
Formoterol—Somnolence—Epirubicin—testicular cancer	0.000224	0.000636	CcSEcCtD
Formoterol—Feeling abnormal—Methotrexate—testicular cancer	0.000222	0.00063	CcSEcCtD
Formoterol—Dyspepsia—Epirubicin—testicular cancer	0.000222	0.000629	CcSEcCtD
Formoterol—Gastrointestinal pain—Methotrexate—testicular cancer	0.00022	0.000625	CcSEcCtD
Formoterol—Hypotension—Doxorubicin—testicular cancer	0.000218	0.000618	CcSEcCtD
Formoterol—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000217	0.000617	CcSEcCtD
Formoterol—Fatigue—Epirubicin—testicular cancer	0.000217	0.000616	CcSEcCtD
Formoterol—Constipation—Epirubicin—testicular cancer	0.000215	0.000611	CcSEcCtD
Formoterol—Pain—Epirubicin—testicular cancer	0.000215	0.000611	CcSEcCtD
Formoterol—Urticaria—Methotrexate—testicular cancer	0.000214	0.000607	CcSEcCtD
Formoterol—Body temperature increased—Methotrexate—testicular cancer	0.000213	0.000604	CcSEcCtD
Formoterol—Abdominal pain—Methotrexate—testicular cancer	0.000213	0.000604	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000212	0.000603	CcSEcCtD
Formoterol—Insomnia—Doxorubicin—testicular cancer	0.000211	0.000598	CcSEcCtD
Formoterol—Dyspnoea—Doxorubicin—testicular cancer	0.000208	0.00059	CcSEcCtD
Formoterol—Feeling abnormal—Epirubicin—testicular cancer	0.000207	0.000589	CcSEcCtD
Formoterol—Somnolence—Doxorubicin—testicular cancer	0.000207	0.000588	CcSEcCtD
Formoterol—Gastrointestinal pain—Epirubicin—testicular cancer	0.000206	0.000585	CcSEcCtD
Formoterol—Dyspepsia—Doxorubicin—testicular cancer	0.000205	0.000582	CcSEcCtD
Formoterol—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000201	0.000571	CcSEcCtD
Formoterol—Fatigue—Doxorubicin—testicular cancer	0.000201	0.00057	CcSEcCtD
Formoterol—Urticaria—Epirubicin—testicular cancer	0.0002	0.000568	CcSEcCtD
Formoterol—Constipation—Doxorubicin—testicular cancer	0.000199	0.000566	CcSEcCtD
Formoterol—Pain—Doxorubicin—testicular cancer	0.000199	0.000566	CcSEcCtD
Formoterol—Abdominal pain—Epirubicin—testicular cancer	0.000199	0.000565	CcSEcCtD
Formoterol—Body temperature increased—Epirubicin—testicular cancer	0.000199	0.000565	CcSEcCtD
Formoterol—Hypersensitivity—Methotrexate—testicular cancer	0.000198	0.000563	CcSEcCtD
Formoterol—Asthenia—Methotrexate—testicular cancer	0.000193	0.000548	CcSEcCtD
Formoterol—Feeling abnormal—Doxorubicin—testicular cancer	0.000192	0.000545	CcSEcCtD
Formoterol—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00019	0.000541	CcSEcCtD
Formoterol—Pruritus—Methotrexate—testicular cancer	0.00019	0.00054	CcSEcCtD
Formoterol—Hypersensitivity—Epirubicin—testicular cancer	0.000185	0.000527	CcSEcCtD
Formoterol—Urticaria—Doxorubicin—testicular cancer	0.000185	0.000525	CcSEcCtD
Formoterol—Abdominal pain—Doxorubicin—testicular cancer	0.000184	0.000523	CcSEcCtD
Formoterol—Body temperature increased—Doxorubicin—testicular cancer	0.000184	0.000523	CcSEcCtD
Formoterol—Diarrhoea—Methotrexate—testicular cancer	0.000184	0.000523	CcSEcCtD
Formoterol—Asthenia—Epirubicin—testicular cancer	0.000181	0.000513	CcSEcCtD
Formoterol—Pruritus—Epirubicin—testicular cancer	0.000178	0.000506	CcSEcCtD
Formoterol—Dizziness—Methotrexate—testicular cancer	0.000178	0.000505	CcSEcCtD
Formoterol—Diarrhoea—Epirubicin—testicular cancer	0.000172	0.000489	CcSEcCtD
Formoterol—Hypersensitivity—Doxorubicin—testicular cancer	0.000172	0.000487	CcSEcCtD
Formoterol—Vomiting—Methotrexate—testicular cancer	0.000171	0.000486	CcSEcCtD
Formoterol—Rash—Methotrexate—testicular cancer	0.00017	0.000482	CcSEcCtD
Formoterol—Dermatitis—Methotrexate—testicular cancer	0.000169	0.000481	CcSEcCtD
Formoterol—Headache—Methotrexate—testicular cancer	0.000169	0.000479	CcSEcCtD
Formoterol—Asthenia—Doxorubicin—testicular cancer	0.000167	0.000475	CcSEcCtD
Formoterol—Dizziness—Epirubicin—testicular cancer	0.000166	0.000473	CcSEcCtD
Formoterol—Pruritus—Doxorubicin—testicular cancer	0.000165	0.000468	CcSEcCtD
Formoterol—Vomiting—Epirubicin—testicular cancer	0.00016	0.000455	CcSEcCtD
Formoterol—Nausea—Methotrexate—testicular cancer	0.00016	0.000454	CcSEcCtD
Formoterol—Diarrhoea—Doxorubicin—testicular cancer	0.000159	0.000453	CcSEcCtD
Formoterol—Rash—Epirubicin—testicular cancer	0.000159	0.000451	CcSEcCtD
Formoterol—Dermatitis—Epirubicin—testicular cancer	0.000159	0.00045	CcSEcCtD
Formoterol—Headache—Epirubicin—testicular cancer	0.000158	0.000448	CcSEcCtD
Formoterol—Dizziness—Doxorubicin—testicular cancer	0.000154	0.000437	CcSEcCtD
Formoterol—Nausea—Epirubicin—testicular cancer	0.00015	0.000425	CcSEcCtD
Formoterol—Vomiting—Doxorubicin—testicular cancer	0.000148	0.000421	CcSEcCtD
Formoterol—Rash—Doxorubicin—testicular cancer	0.000147	0.000417	CcSEcCtD
Formoterol—Dermatitis—Doxorubicin—testicular cancer	0.000147	0.000417	CcSEcCtD
Formoterol—Headache—Doxorubicin—testicular cancer	0.000146	0.000414	CcSEcCtD
Formoterol—Nausea—Doxorubicin—testicular cancer	0.000138	0.000393	CcSEcCtD
